Fighting the Opioid Epidemic with New Knowledge: Univ. Of Michigan and Harvard Team Up for Opioid Summit
Free webcast will share new findings from efforts to study and address the epidemic from many angles
Newswise — With 130 Americans dying every day from opioid overdoses, and 2 million suffering from disorders related to prescription and non-prescription opioids, the University of Michigan and Harvard University have teamed up to hold an online event focused on confronting the opioid epidemic by sharing research and expertise from their faculty.
The event, available through a free public webcast, will take place on Friday, May 10 from 8 a.m. to 3:30 p.m.
Organized as part of a broader collaboration between the two institutions and titled “Opioids: Policy to Practice”, the webcast is available worldwide.
The top official for opioid epidemic response at the U.S. Department of Health and Human Services, Admiral Brett P. Giroir, M.D., will give the keynote address. Giroir is Assistant Secretary for Health and senior advisor to the Secretary of HHS.
The summit aims to give policymakers, community health leaders, the business community and families affected by the opioid epidemic the latest findings from U-M and Harvard research, as well as updates on initiatives and public policies aimed at addressing specific aspects of the epidemic.
A full list of speakers, schedule of talks and webcast registration link can be found at http://opioidsummit.umich.edu. Those who register will receive an email with the link to watch the webcast and ask questions of speaker via a chat window.
The event will also be live-tweeted using the hashtag #OpSummit19. Speakers’ slides and a video recording will be available after the event via the website.
Last year, U-M launched Opioid Solutions, a network that encourages and coordinates efforts across campus and beyond to find solutions to the opioid epidemic.
Located at https://opioids.umich.edu/, it showcases U-M expertise of all kinds -- from the basic science of studying opioids’ impact on the brain and body, to safe prescribing recommendations for clinicians, to the evaluation of efforts to prevent and treat opioid use disorders.
U-M also offers an email newsletter of updates about this work; anyone may sign up on the website to receive it.